BAJAJ BROKING

Notification close image
No new Notification messages
card image
Travel Food Services IPO is Open!
Apply for the Travel Food Services IPO through UPI in just minutes.
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

16807

532998

LOTUSEYE

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

LOTUS EYE HOSP & INST L performance

Today’s low

Today’s high

₹ 70.81 ₹ 72.50
₹ 71.87

52 week low

52 week high

₹ 54.99 ₹ 90.98
₹ 71.87

Open Price

₹ 71.42

Prev. Close

₹ 71.42

Volume (Shares)

10653.00

Total traded value

₹ 7.65

Upper Circuit

₹ 85.70

Lower Circuit

₹ 57.13

info

LOTUS EYE HOSP & INST L Share Price Update

As of the latest trading session, LOTUS EYE HOSP & INST L share price is currently at ₹ 72.5, which is up by ₹ 1.08 from its previous closing. Today, the stock has fluctuated between ₹ 70.81 and ₹ 72.50. Over the past year, LOTUS EYE HOSP & INST L has achieved a return of 21.71 %. In the last month alone, the return has been 1.38 %. Read More...

Investment Returns

Over 1 Month 1.38% Over 3 Months 5.76% Over 6 Months 0.72% Over 1 Year 21.71%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

LOTUS EYE HOSP & INST L fundamentals


  • Market cap (Cr)

    149.50

  • P/E Ratio (TTM)

    199.86

  • Beta

    1.00

  • Book Value / share

    28.84

  • Return on equity

    4.97%

  • EPS (TTM)

    0.35

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    0.25

info icon alternate text
  • Market cap (Cr)

    149.60

  • P/E Ratio (TTM)

    199.86

  • Beta

    0.95

  • Book Value / share

    28.84

  • Return on equity

    4.97%

  • EPS (TTM)

    0.35

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    0.25

info icon alternate text

LOTUS EYE HOSP & INST L Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars MAR 2025 (Values in Cr)
Revenue 11.51
Operating Expense 11.19
Net Profit 0.25
Net Profit Margin (%) 2.17
Earnings Per Share (EPS) 0.12
EBITDA 0.35
Effective Tax Rate (%) 70.23
Particulars DEC 2024 (Values in Cr)
Revenue 12.25
Operating Expense 12.89
Net Profit -0.24
Net Profit Margin (%) -1.95
Earnings Per Share (EPS) -0.11
EBITDA 1.01
Effective Tax Rate (%) 44.18
Particulars SEP 2024 (Values in Cr)
Revenue 12.91
Operating Expense 13.07
Net Profit 0.10
Net Profit Margin (%) 0.77
Earnings Per Share (EPS) 0.05
EBITDA 1.42
Effective Tax Rate (%) 9.09
Particulars JUN 2024 (Values in Cr)
Revenue 12.89
Operating Expense 12.34
Net Profit 0.62
Net Profit Margin (%) 4.80
Earnings Per Share (EPS) 0.30
EBITDA 1.98
Effective Tax Rate (%) 26.74
Particulars MAR 2024 (Values in Cr)
Revenue 10.88
Operating Expense 11.28
Net Profit 0.02
Net Profit Margin (%) 0.18
Earnings Per Share (EPS) 0.01
EBITDA 1.16
Effective Tax Rate (%) -200.00
Particulars MAR 2025 (Values in Cr)
Revenue 49.56
Operating Expense 49.50
Net Profit 0.74
Net Profit Margin (%) 1.49
Earnings Per Share (EPS) 0.36
EBITDA 4.75
Effective Tax Rate (%) 46.37
Particulars MAR 2024 (Values in Cr)
Revenue 48.21
Operating Expense 45.51
Net Profit 2.91
Net Profit Margin (%) 6.03
Earnings Per Share (EPS) 1.40
EBITDA 7.84
Effective Tax Rate (%) 27.43
Particulars MAR 2023 (Values in Cr)
Revenue 47.04
Operating Expense 42.54
Net Profit 4.08
Net Profit Margin (%) 8.67
Earnings Per Share (EPS) 1.96
EBITDA 8.73
Effective Tax Rate (%) 27.78
Particulars MAR 2022 (Values in Cr)
Revenue 38.91
Operating Expense 35.69
Net Profit 2.98
Net Profit Margin (%) 7.65
Earnings Per Share (EPS) 1.44
EBITDA 6.72
Effective Tax Rate (%) 27.13
Particulars MAR 2021 (Values in Cr)
Revenue 32.37
Operating Expense 31.20
Net Profit 1.57
Net Profit Margin (%) 4.85
Earnings Per Share (EPS) 0.75
EBITDA 4.38
Effective Tax Rate (%) 21.10
Particulars MAR 2024 (Values in Cr)
Book Value / Share 28.57
ROE % 4.97
ROCE % 7.06
Total Debt to Total Equity 0.02
EBITDA Margin 16.47
Particulars MAR 2023 (Values in Cr)
Book Value / Share 27.69
ROE % 7.27
ROCE % 10.18
Total Debt to Total Equity 0.02
EBITDA Margin 18.77
Particulars MAR 2022 (Values in Cr)
Book Value / Share 26.26
ROE % 5.55
ROCE % 7.81
Total Debt to Total Equity 0.02
EBITDA Margin 17.48
Particulars MAR 2021 (Values in Cr)
Book Value / Share 25.34
ROE % 3.02
ROCE % 4.01
Total Debt to Total Equity 0.01
EBITDA Margin 13.78
Particulars MAR 2020 (Values in Cr)
Book Value / Share 24.65
ROE % 2.86
ROCE % 4.59
Total Debt to Total Equity 0.01
EBITDA Margin 12.03
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 7.04
Total Assets 66.62
Total Liabilities 66.62
Total Equity 59.40
Share Outstanding 20796330
Price to Book Ratio 1.98
Return on Assets (%) 4.37
Return on Capital (%) 4.91
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 8.41
Total Assets 63.18
Total Liabilities 63.18
Total Equity 57.57
Share Outstanding 20796330
Price to Book Ratio 2.10
Return on Assets (%) 6.45
Return on Capital (%) 7.08
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 8.84
Total Assets 61.60
Total Liabilities 61.60
Total Equity 54.60
Share Outstanding 20796330
Price to Book Ratio 2.03
Return on Assets (%) 4.84
Return on Capital (%) 5.47
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 9.91
Total Assets 59.22
Total Liabilities 59.22
Total Equity 52.69
Share Outstanding 20796330
Price to Book Ratio 1.65
Return on Assets (%) 2.64
Return on Capital (%) 2.98
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 7.01
Total Assets 58.10
Total Liabilities 58.10
Total Equity 51.25
Share Outstanding 20796330
Price to Book Ratio 0.95
Return on Assets (%) 1.83
Return on Capital (%) 2.08
Particulars MAR 2024 (Values in Cr)
Net Income 4.00
Cash from Operations 6.68
Cash from Investing -4.63
Cash from Financing -3.40
Net change in Cash -2.35
Free Cash Flow 12.25
Particulars MAR 2023 (Values in Cr)
Net Income 5.65
Cash from Operations 5.79
Cash from Investing -2.19
Cash from Financing -1.70
Net change in Cash 0.48
Free Cash Flow 8.89
Particulars MAR 2022 (Values in Cr)
Net Income 4.10
Cash from Operations 5.25
Cash from Investing -3.93
Cash from Financing -1.57
Net change in Cash -1.09
Free Cash Flow 9.94
Particulars MAR 2021 (Values in Cr)
Net Income 1.91
Cash from Operations 3.02
Cash from Investing 0.48
Cash from Financing -0.31
Net change in Cash 2.89
Free Cash Flow 3.50
Particulars MAR 2020 (Values in Cr)
Net Income 2.14
Cash from Operations 5.24
Cash from Investing -0.68
Cash from Financing 0.13
Net change in Cash 4.42
Free Cash Flow 7.66
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 7554.30 75.12 13.23 108619.24 6002.15 / 7599.75
FORTIS MALAR HOSPITALS LIMITED 72.99 347.57 4.53 136.80 51.01 / 98.70
SHREE PACETRONIX LTD. 84.74 40.74 2.21 30.50 61.11 / 221.50
TRANSGENE BIOTEK LTD. 4.85 0.00 3.66 36.75 3.22 / 10.84
VIMTA LABS LIMITED 470.85 34.47 6.11 2095.54 235.00 / 591.50
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 7554.30 83.79 12.43 108619.24 6002.15 / 7599.75
Surlux Diagnostic Ltd 1.40 0.84 0.13 0.49 0.00 / 0.00
CHENNAI MEENAKSHI MULTISPECIAL 33.06 0.00 -13.06 24.70 28.34 / 59.90
KOVAI MEDICAL CENTER & HOSPITA 6130.35 32.10 6.17 6706.60 4067.50 / 6400.00

LOTUS EYE HOSP & INST L Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
71.87 0.63 redarrow
red-green-graph indicator
1 Bearish
15 Bullish
  • 5 Days 71.60
  • 26 Days 71.70
  • 10 Days 71.50
  • 50 Days 71.30
  • 12 Days 71.50
  • 100 Days 70.10
  • 20 Days 71.60
  • 200 Days 69.80
71.84 PIVOT

First Support

70.39

First Resistance

72.87

Second Support

69.36

Second Resistance

74.32

Third Support

67.91

Third Resistance

75.35

RSI

50.99

ADX

13.14

MACD

-0.17

Williams % R

-31.18

Commodity Channel Index (CCI)

-9.81

Date

2025-07-04

Week

9302.00

Same Day

8892.00

Month

12364.00

1 Year

1.00

3 Year

0.82

Over 1 Month

1.38%

down

Over 1 Year

21.71%

down

Over 3 Months

5.76%

down

Over 3 Years

11.35%

down

Over 6 Months

0.72%

down

Over 5 Years

17.56%

down

LOTUS EYE HOSP & INST L shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
59.74%
Promoter Holdings
40.22%
FII
0.0%
DII
0.03%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Sangeetha S 3939909.0 (18.95%) Shareholding of Promoter and Promoter Group
Kavetha Sundaramoorthy 3905356.0 (18.78%) Shareholding of Promoter and Promoter Group
Kovai Purani Finance Private Limited 1386805.0 (6.67%) Public Shareholding
Vramath Investment Consultancy Pvt Ltd 1006584.0 (4.84%) Public Shareholding
Rajiv Choudhary 855523.0 (4.11%) Public Shareholding
Sangeeta Choudhary 815000.0 (3.92%) Public Shareholding
Kaliannagounder Sundaramoorthy 501837.0 (2.41%) Shareholding of Promoter and Promoter Group
Vramath Financial Services Pvt Ltd 414536.0 (1.99%) Public Shareholding
Mahendran Devika 409522.0 (1.97%) Public Shareholding
K S Ramalingam 298360.0 (1.43%) Public Shareholding
Urvija Choudhary 251018.0 (1.21%) Public Shareholding
Sundaramoorthy Rajkumar 17200.0 (0.08%) Shareholding of Promoter and Promoter Group

News

Left Arrow
Right Arrow

LOTUS EYE HOSP & INST L corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
18 Sep 2023 0.5 Final 18 Sep 2023 Equity shares
08 Sep 2022 0.5 Final 10 Sep 2022 Equity shares
08 Sep 2021 0.5 Final 11 Sep 2021 Equity shares
14 Sep 2018 0.5 Final 18 Sep 2018 Equity shares
02 Aug 2017 0.5 Final 04 Aug 2017 Equity shares
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
18 Sep 2023 0.5 Final 18 Sep 2023 Equity shares
08 Sep 2022 0.5 Final 10 Sep 2022 Equity shares
08 Sep 2021 0.5 Final 11 Sep 2021 Equity shares
14 Sep 2018 0.5 Final 18 Sep 2018 Equity shares
02 Aug 2017 0.5 Final 04 Aug 2017 Equity shares
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

LOTUS EYE HOSP & INST L Share Price

Lotus Eye Hospital & Institute Ltd, a trust hospital, was originally incorporated as 'Kalaivani Health Centre Pvt. Limited' on 14 March, 1997. The name of the Company was changed to 'Lotus Eye Care Hospital Pvt. Limited' on 23 January, 2006 and later on, the Company was converted into a Public Limited Company on October 16, 2007 and subsequently, the name was changed to Lotus Eye Hospital & Institute Limited on April 12, 2013. Dr S.K.Sundaramoorthy promoted the Company.

Lotus Eye Care Hospital is the state of art eye care hospital group successfully functioning in South India with specialization in super-specialty service related to eye care. The Company is engaged in the field of Ophthalmology (Eye) and its related operation. It has 7 centres at Peelamedu, R.S. Puram, Mettupalayam, Tirupur, Salem, Cochin and Mulanthuruthy.

Lotus has two centers in Coimbatore, one in down town and another in civil aerodrome inaugurated in the year 2002. The Salem Center is located in the heart of the city and it was started in the year 2004. The Tirupur Center started in 2007 is also functioning in prime location in the city. These hospitals have hi-tech eye care equipments and ophthalmic experts backed by well-trained paramedical and administrative team. All the centers have fully computerized modern setup manned by medical and administrative staff. The network of eye care hospitals has 9 operation theatres and 3 Lasik laser equipments. Most of the eye operations are performed as a day care procedure and therefore the company has maintained optimum number of beds. The hospitals total bed strength of all the centers is 120 beds excluding eye camp beds.

In the year 1998, Lotus introduced Multi Scan Lasik and in the year 2002 Wave front based Esiris Custom Lasik for the first time in India. Lotus was the first Eye hospital in South East Asia to have Epilasik in July 2004. In the year June 2005 Lotus introduced the most advanced technology of Zyoptix and combined two superior technologies Epilasik and Zyoptix known as Zyoptix Integrated Epilasik to achieve supervision.

In the year 2006-2007, Dr. S.K.S.Eye Care Centre Pvt. Ltd., (Dr S K Sundaramoorthy promoter of the company) was merged with company w.e.f. 01 December, 2006.

The Company opened a new Center in Tirupur in June, 2007. The Company raised Rs 38 Crores by issue of 1,00,00,000 equity shares of Rs. 10 each at premium of Rs. 28 per share to finance the part of expansion project on 27 June, 2008 and the shares got listed both Bombay Stock Exchange and National Stock Exchange on 11th July, 2008.

It launched Intralasa Lasik/ Zyoptix Laser Technology in 2009; opened a new center in Mettupalayam in 2010; opened new center in Kochi, Kerala; introduced Zyoptix Supracor in Tamilnadu; launched Zyoptix Ultimate 217P technology in 2011. In 2013, it launched LenSx for Laser Cataract and Laser Corneal Surgery; in 2014, opened Mulanthuruthy Centre in Kerala; launched Kerala's 1st ReLEx SMILE at Kochi in 2016; launched Schwind Amaris 750Hz Touch Free Lasik Technology at RS Puram in 2019 and opened Saravanampatti Centre in Coimbatore in 2023.

Parent organization Indian Private
NSE symbol LOTUSEYE
Founded 1997
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Lotus Eye Hospital & Institute Ltd?

Answer Field

Lotus Eye Hospital & Institute Ltd share price is for NSE ₹ 72.50 & for BSE ₹ 71.95 as on Jul 04 2025 03:29 PM.

What is the Market Cap of Lotus Eye Hospital & Institute Ltd Share?

Answer Field

The market cap of Lotus Eye Hospital & Institute Ltd for NSE ₹ 149.50 & for BSE ₹ 0.00 as on Jul 04 2025 03:29 PM.

What is the 52 Week High and Low of Lotus Eye Hospital & Institute Ltd?

Answer Field

The 52 Week High and Low of Lotus Eye Hospital & Institute Ltd for NSE is ₹ 90.98 and ₹ 54.99 and for BSE is ₹ 91.00 and ₹ 55.31.

What is 1 year return for Lotus Eye Hospital & Institute Ltd?

Answer Field

The 1 year returns on the stock has been 21.71%.

What is the P/E Ratio of Lotus Eye Hospital & Institute Ltd Share?

Answer Field

As on Jul 04 2025 03:29 PM the price-to-earnings (PE) ratio for Lotus Eye Hospital & Institute Ltd share is 199.86.

What is the PB ratio of Lotus Eye Hospital & Institute Ltd Share?

Answer Field

As on Jul 04 2025 03:29 PM, the price-to-book (PB) ratio for Lotus Eye Hospital & Institute Ltd share is 28.84.

How to Buy Lotus Eye Hospital & Institute Ltd Share?

Answer Field

You can trade in Lotus Eye Hospital & Institute Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Lotus Eye Hospital & Institute Ltd Share on Bajaj Broking App?

Answer Field

To buy Lotus Eye Hospital & Institute Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Lotus Eye Hospital & Institute Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|